Yaron A. Moshel, MD, PhD
See Dr. Moshel's profile on Healthgrades.
ANS ǀ Altair Health Morristown
Overlook Medical Center
Atlantic Neuroscience Institute
99 Beauvoir Avenue
Carol G. Simon Cancer Center
Brain, skull base, pituitary and spine tumors, functional brain mapping, minimally invasive endoscopy, microsurgery and stereotactic radiosurgery
Dr. Moshel is board-certified in neurosurgery and fellowship-trained in neuro-oncology, brain tumor surgery, stereotactic and skull base surgery.
Dr. Yaron Moshel is co-director of the Gerald J. Glasser Brain Tumor Center at Atlantic Health System's Overlook Medical Center in Summit and part of the neurosurgical team at ANS in Morristown. He is also Clinical Assistant Professor of Neurosurgery at NYU Langone Medical Center.
Dr. Moshel is one of a select few surgeons who specialize in removing deep-seated brain tumors using technology that includes computer-guided navigation, awake intraoperative brain mapping, endoscopy, and microsurgery. Dr. Moshel is a vital part of Overlook Medical Center's CyberKnife Program making it the largest CyberKnife Program in the tri-state region for the treatment of brain tumors. Dr. Moshel is also actively involved in advancing the treatment of brain tumors and actively participates in national multicenter clinical trials, most recently working with an autologous dendritic cell vaccine and on a retroviral vaccine trial for recurrent brain tumors.
Previously Assistant Professor of Neurosurgery at Thomas Jefferson University Hospital in Philadelphia, Dr. Moshel's clinical interests and neurosurgical abilities extend beyond the treatment of brain tumors. He is experienced in the surgical approaches for skull base and spine tumors and in endoscopic transnasal surgery for pituitary and skull base lesions. His practice also encompasses the surgical treatment of epilepsy and minimally invasive treatment of trigeminal neuralgia.
Dr. Moshel received his Bachelor of Science with Honors from New York University and his M.D. and Ph.D. degrees from State University of New York in Brooklyn, NY. He was elected into the Alpha Omega Alpha (AOA) honor society and was the graduate school class valedictorian. His residency and Chief residency training in Neurosurgery were completed at New York University Medical Center and Bellevue Hospital Center in NY, New York. Dr. Moshel also completed advanced fellowship training in Neuro-Oncology, Stereotactic and Skull Base Surgery at New York University Medical Center. He further completed a research fellowship in Minimally Invasive Endoscopic Skull Base Surgery at New York Presbyterian Hospital/Weill-Cornell Medical Center.
Dr. Moshel is Board Certified by the American Board of Neurological Surgeons and he is a member of the American Association of Neurological Surgeons, the Congress of Neurological Surgeons, North American Skull Base Society, AANS/CNS Joint Section on Tumors and Joint Section on Disorders of the Spine. He is actively involved in the training and mentoring of neurosurgical residents and serves as a reviewer for the Scientific Program Committee of the AANS Tumor Section. Additionally, Dr. Moshel has visited with several internationally renowned neurosurgeons and received numerous awards for his academic excellence and neurosurgical research including grant support from the American Cancer Society. As an active contributor to neurosurgical research, he has published many scholarly articles in the Journal of Neurosurgery, Neurosurgery and Epilepsia. He has also authored several book chapters on advances in stereotactic and minimally invasive spine and brain surgery.
Dr. Moshel is actively involved in the ANS Center for Hope brain tumor support group and his most important daily focus is on patient care. He has been recognized for his unwavering commitment and dedication to his patients and strives to further cancer treatments with them in mind.
Dr. John J. Knightly, Dr. Yaron A. Moshel, Dr. Michael E. Rudman and Dr. Richard P. Winne, Jr. Named 2020 Jersey Choice Top Doctors
Admin2020-11-18T16:18:10-05:00November 12th, 2020|
In its annual Top Docs listing, New Jersey Monthly has named ANS | Altair Health's Dr. John J. Knightly, Dr. Yaron A. Moshel, Dr. Michael E. Rudman and Dr. Richard P. Winne, Jr. 2020 Jersey Choice Top Doctors.
When is Neck Pain More than Just Stress?
Admin2020-11-18T16:08:49-05:00November 9th, 2020|
After being told her neck pain was due to stress, 34-year-old Erika Kiel discovered she had a malignant tumor in her brainstem and made an incredible recovery following neurosurgery.
Battling a Brain Tumor, Single Mother Finds Neurosurgeon Who Helps Her Put Kids First
Admin2020-11-18T16:29:30-05:00August 15th, 2020|
Susan Pisarchik, 48, discovered her symptoms weren't just signs of middle age and that she needed to undergo complex brain surgery at the base of her skull – quickly.
Top-Tier Neuro-Oncologists Join Brain Tumor Center Team
Admin2020-11-18T16:39:47-05:00August 3rd, 2020|
For the more than one thousand patients cared for here each year, the Gerald J. Glasser Brain Tumor Center delivers state-of-the-art care while easing minds, comforting families, and keeping hope alive.
Healing the Brain – Sudden Seizure Leads to Brain Tumor Discovery
Admin2020-12-09T17:24:06-05:00July 3rd, 2020|
At Overlook, they met neurosurgeon Yaron Moshel, MD, PhD, co-director of the Gerald J. Glasser Brain Tumor Center. He explained that MRI scans revealed Sam had a brain tumor and an arteriovenous malformation (AVM) – an abnormal tangle of veins and arteries that interferes with blood circulation – and both needed to be removed.
From Brain Tumor to Best Man
Admin2020-11-18T16:13:15-05:00June 3rd, 2020|
"I had the shock of my life when the physician told me I had a brain tumor," says Joe, who was immediately admitted to the Neuro Intensive Care Unit for further evaluation by the Gerald J. Glasser Brain Tumor Center team.
After Rare Brain Tumor Diagnosis, Aspiring New Jersey Lawyer Powers Through Cardiac Surgery and Neurosurgery
Admin2020-11-18T16:37:09-05:00May 4th, 2020|
Unusual circumstances bring surgeons together to partner, putting the patient first.
Top Lawyer Credits Health After Brain Surgery to NJ-Based Neurosurgical Care
Admin2020-11-30T19:06:42-05:00April 8th, 2020|
Top Lawyer Credits Health After Brain Surgery to NJ-Based Neurosurgical Care Mark Boyland went from brain tumor-induced seizures to white water sports in seven weeks. Mark Boyland returned [read more]
Beating the odds: High-risk neurosurgery saves a young man's life
Admin2020-04-24T15:52:49-04:00March 31st, 2020|
Beating the odds: High-risk neurosurgery saves a young man's life Dr. Yaron Moshel of Atlantic NeuroSurgical Specialists successfully removed a malignant tumor from a 23-year-old's brain stem -- despite [read more]
ANS Center for Hope Foundation gives new patients battling brain tumors chance for healing
Admin2020-03-31T00:55:56-04:00March 28th, 2020|
ANS Center for Hope Foundation gives new patients battling brain tumors chance for healing The ANS Center for Hope Foundation's Brain Tumor Support Group brings patients and caregivers together in [read more]
Paralyzed Brother of Famed 'Shark Tank' Star Walks Again After Life-Altering Spine Surgery
Paralyzed Brother of Famed 'Shark Tank' Star Walks Again After Life-Altering Spine Surgery When John Corcoran, owner of Statewide Roofing and Siding in Edgewater and brother of Shark Tank millionaire, Barbara [read more]
Immunotherapy Clinical Trial Aims to Combat Brain Cancer
Immunotherapy Clinical Trial Aims to Combat Brain Cancer A Phase 2/3 clinical trial called Toca 5 - investigating a retroviral gene therapy treatment in patients with recurrent brain cancer - is actively [read more]
Atlantic NeuroSurgical Specialists (ANS) Introduce Noninvasive Treatment for Brain Tumor Patients
Admin2020-12-11T14:21:15-05:00January 30th, 2015|
Doctors at Atlantic NeuroSurgical Specialists (ANS) have added a new and innovative form of therapy to their treatment arsenal in the battle against glioblastoma multiforme (GBM). Affecting nearly 10,000 Americans annually, GBM is the one of the most aggressive and difficult-to-control forms of primary brain tumors in the United States.